Waverley Pharma Inc. They are dedicated to the development and commercialization of safe, effective, and affordable therapeutics. With a focus on the generic oncology market in the United Kingdom (U.

K. ) and North America, Waverley Pharma offers a range of innovative generic oncology products. Currently, they have five generic oncology products available in the U.

K. Committed to lowering healthcare costs and improving patients' quality of life, Waverley Pharma is passionate about providing affordable prescription medicines. They have a strong pipeline of products at different stages of development through strategic partnerships.

Under the leadership of Larry Thiessen, President and CEO, and Haaris Uddin, CFO, who bring extensive pharmaceutical and financial expertise, Waverley Pharma is poised for continued growth and success. Stay connected with Waverley Pharma Inc